Your browser doesn't support javascript.
loading
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL).
Genescà, Eulàlia; Morgades, Mireia; González-Gil, Celia; Fuster-Tormo, Francisco; Haferlach, Claudia; Meggendorfer, Manja; Montesinos, Pau; Barba, Pere; Gil, Cristina; Coll, Rosa; Moreno, María-José; Martínez-Carballeira, Daniel; García-Cadenas, Irene; Vives, Susana; Ribera, Jordi; González-Campos, José; Díaz-Beya, Marina; Mercadal, Santiago; Artola, María-Teresa; Cladera, Antonia; Tormo, Mar; Bermúdez, Arancha; Vall-Llovera, Ferran; Martínez-Sánchez, Pilar; Amigo, María-Luz; Monsalvo, Silvia; Novo, Andrés; Cervera, Marta; García-Guiñon, Antonio; Ciudad, Juana; Cervera, José; Hernández-Rivas, Jesús-María; Granada, Isabel; Haferlach, Torsten; Orfao, Alberto; Solé, Francesc; Ribera, Josep-Maria.
Affiliation
  • Genescà E; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain. Electronic address: egenesca@carrerasresearch.org.
  • Morgades M; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Spain.
  • González-Gil C; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.
  • Fuster-Tormo F; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.
  • Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Montesinos P; Hospital Universitari Politècnic La Fe & CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Barba P; Clinical Hematology Service, Hospital Universitari de la Vall d'Hebron, Barcelona, Spain.
  • Gil C; Clinical Hematology Service, Hospital General de Alicante, Alicante, Spain.
  • Coll R; Clinical Hematology Service, Hospital Josep Trueta-ICO, Girona, Spain.
  • Moreno MJ; Clinical Hematology Service, Hospital Virgen de la Victoria, Málaga, Spain.
  • Martínez-Carballeira D; Clinical Hematology Service, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • García-Cadenas I; Clinical Hematology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Vives S; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Spain.
  • Ribera J; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.
  • González-Campos J; Clinical Hematology Service, Hospital Virgen del Rocío, Sevilla, Spain.
  • Díaz-Beya M; Clinical Hematology Service, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Mercadal S; Clinical Hematology Service, Hospital Duran i Reynals-ICO, Hospitalet del LLobregat, Spain.
  • Artola MT; Clinical Hematology Service, Hospital Universitario de Donostia, Donostia, Spain.
  • Cladera A; Clinical Hematology Service, Hospital Son Llàtzer, Palma de Mallorca, Spain.
  • Tormo M; Clinical Hematology Service, Hospital Clínico de Valencia, Valencia, Spain.
  • Bermúdez A; Clinical Hematology Service, Hospital Marqués de Valdecilla, Santander, Spain.
  • Vall-Llovera F; Clinical Hematology Service, Hospital Mútua de Terrassa, Terrassa, Spain.
  • Martínez-Sánchez P; Clinical Hematology Service, Hospital 12 de Octubre, Madrid, Spain.
  • Amigo ML; Clinical Hematology Service, Hospital Morales Meseguer, Murcia, Spain.
  • Monsalvo S; Clinical Hematology Service, Hospital Gregorio Marañón, Madrid, Spain.
  • Novo A; Clinical Hematology Service, Hospital Son Espases, Palma de Mallorca, Spain.
  • Cervera M; Clinical Hematology Service, Hospital Joan XXIII, Tarragona, Spain.
  • García-Guiñon A; Clinical Hematology Service, Hospital Arnau de Vilanova, Lleida, Spain.
  • Ciudad J; Centro de Investigación del Cáncer (IBMCC-CSIC/USAL) (CIC), Hospital Clínico Universitario de Salamanca (HUS), Instituto Bio-Sanitario de Salamanca (IBSAL), CIBERONC, Salamanca, Spain.
  • Cervera J; Hospital Universitari Politècnic La Fe & CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Hernández-Rivas JM; Hospital Clínico Universitario de Salamanca (HUS), Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Centro de Investigación del Cáncer (CIC), Spain.
  • Granada I; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Spain.
  • Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Orfao A; Centro de Investigación del Cáncer (IBMCC-CSIC/USAL) (CIC), Hospital Clínico Universitario de Salamanca (HUS), Instituto Bio-Sanitario de Salamanca (IBSAL), CIBERONC, Salamanca, Spain.
  • Solé F; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.
  • Ribera JM; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Spain.
Leuk Res ; 109: 106612, 2021 10.
Article in En | MEDLINE | ID: mdl-34139642
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosome Aberrations / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2021 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosome Aberrations / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2021 Document type: Article Country of publication: United kingdom